Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $665.30 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $157.42 | 9 | $0 (2020) |
| ABBVIE INC. | $111.87 | 7 | $0 (2022) |
| GlaxoSmithKline, LLC. | $85.72 | 6 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $64.01 | 4 | $0 (2021) |
| Amgen Inc. | $40.15 | 2 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $37.17 | 3 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $31.61 | 2 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $30.32 | 2 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $27.62 | 2 | $0 (2021) |
| Novo Nordisk Inc | $23.12 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.12 | 1 | Novo Nordisk Inc ($23.12) |
| 2022 | $13.61 | 1 | ABBVIE INC. ($13.61) |
| 2021 | $196.59 | 12 | AbbVie Inc. ($85.54) |
| 2020 | $91.81 | 6 | Sunovion Pharmaceuticals Inc. ($31.61) |
| 2019 | $26.23 | 2 | Janssen Pharmaceuticals, Inc ($13.60) |
| 2018 | $28.03 | 2 | Synergy Pharmaceuticals Inc ($17.08) |
| 2017 | $285.91 | 18 | Allergan Inc. ($133.54) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Obesity | ||||||
| 03/09/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Cardio-renal | ||||||
| 08/10/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardio-renal | ||||||
| 07/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/15/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Bone Health | ||||||
| 06/10/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/26/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/12/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2021 | AbbVie Inc. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/25/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/29/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Respiratory | ||||||
| 09/04/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Respiratory | ||||||
| 07/22/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.38 | General |
| 06/26/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $12.72 | General |
| 02/25/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Bone Health | ||||||
| 12/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/18/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/22/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Gastroenterology | ||||||
| 02/21/2018 | Allergan Inc. | BYVALSON (Drug), BYSTOLIC | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/20/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), DULERA | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 68 | 70 | $11,484 | $4,598 |
| 2021 | 23 | 1,887 | 2,886 | $224,252 | $73,953 |
| 2020 | 36 | 2,733 | 4,950 | $418,188 | $134,328 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 28 | $6,720 | $2,516 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 30 | $4,500 | $2,045 | 45.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 11 | 12 | $264.00 | $37.44 | 14.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 225 | 338 | $81,120 | $25,592 | 31.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 172 | 235 | $35,250 | $13,222 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 71 | 71 | $11,005 | $9,265 | 84.2% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 88 | 88 | $2,990 | $2,794 | 93.5% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 15 | 290 | $8,120 | $2,586 | 31.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 167 | 187 | $14,025 | $2,491 | 17.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 192 | 231 | $16,170 | $2,439 | 15.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 196 | 241 | $6,025 | $1,873 | 31.1% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 19 | 19 | $5,700 | $1,772 | 31.1% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 15 | 313 | $7,825 | $1,765 | 22.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 92 | 102 | $5,304 | $1,714 | 32.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 78 | 78 | $2,440 | $1,485 | 60.8% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 23 | 29 | $4,350 | $1,312 | 30.2% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 32 | 32 | $1,280 | $1,238 | 96.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2021 | 43 | 43 | $2,365 | $830.33 | 35.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 68 | 86 | $3,010 | $825.35 | 27.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 201 | 273 | $2,730 | $819.00 | 30.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 81 | 90 | $9,900 | $802.78 | 8.1% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 15 | 16 | $1,280 | $424.00 | 33.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 21 | 25 | $1,300 | $256.91 | 19.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 28 | 28 | $420.00 | $168.21 | 40.1% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 12 | 27 | $675.00 | $140.37 | 20.8% |
About Dr. Norman Jennings, M.D
Dr. Norman Jennings, M.D is a Family Medicine healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659378925.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Norman Jennings, M.D has received a total of $665.30 in payments from pharmaceutical and medical device companies, with $23.12 received in 2024. These payments were reported across 42 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($665.30).
As a Medicare-enrolled provider, Jennings has provided services to 4,688 Medicare beneficiaries, totaling 7,906 services with total Medicare billing of $212,879. Data is available for 3 years (2020–2022), covering 62 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Athens, TX
- Active Since 07/01/2005
- Last Updated 10/16/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1659378925
Products in Payments
- VRAYLAR (Drug) $78.86
- ANORO (Drug) $72.09
- XARELTO (Drug) $64.01
- UBRELVY (Drug) $62.70
- LINZESS (Drug) $49.39
- EVENITY (Biological) $40.15
- UTIBRON NEOHALER (Drug) $31.61
- Kerendia (Drug) $30.32
- ENTRESTO (Drug) $27.62
- ASMANEX (Drug) $23.55
- Wegovy (Drug) $23.12
- VIBERZI (Drug) $22.92
- BYSTOLIC (Drug) $17.70
- Trulance (Drug) $17.08
- CREON (Drug) $14.05
- BREO (Drug) $13.63
- BELSOMRA (Drug) $13.62
- NUEDEXTA (Drug) $13.20
- CHANTIX (Drug) $12.63
- BYVALSON (Drug) $10.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681